Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

David R Piwnica-Worms

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2120-7217; OpenAlex author ID A5051752608; NIH RePORTER profile ID 1877652. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
1
Labs led
0
Collaborators
54
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 grant · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 2 papers · 2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 8

  1. Imaging Reactive Oxygen Species with L-012 Reveals Neutrophil Extracellular Trap Formation in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/antiox14121473↗
  2. Hypoxia-activated prodrug and antiangiogenic therapies cooperatively treat pancreatic cancer but elicit immunosuppressive G-MDSC infiltration. Co-author DOI 10.1172/jci.insight.169150↗
  3. Tumor-associated nonmyelinating Schwann cell-expressed PVT1 promotes pancreatic cancer kynurenine pathway and tumor immune exclusion. Co-author DOI 10.1126/sciadv.add6995↗
  4. Author Correction: Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/s41586-022-05062-9↗
  5. Metabolic requirement for GOT2 in pancreatic cancer depends on environmental context. Co-author DOI 10.7554/elife.73245↗
  6. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer. Co-author DOI 10.1021/acs.jproteome.9b00132↗
  7. Simultaneous inhibition of hedgehog signaling and tumor proliferation remodels stroma and enhances pancreatic cancer therapy. Co-author DOI 10.1016/j.biomaterials.2018.01.014↗
  8. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Co-author DOI 10.1038/nature14581↗

Grants 1

  1. Employing mouse models to translate early detection of pancreas cancer R01CA195733↗

Closest collaborators

The 25 strongest of 54 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Raghu Kalluri · 2 shared papers, 1 shared grant, 2015–2022 · strength 0.46
  2. Michael A. Curran · 2 shared papers, 2023–2024 · strength 0.35
  3. Angisha Basnet · 1 shared paper, 2025 · strength 0.27
  4. Tracy W. B. Liu · 1 shared paper, 2025 · strength 0.27
  5. Brian A. Boone · 1 shared paper, 2025 · strength 0.27
  6. Akash R. Boda · 1 shared paper, 2024 · strength 0.23
  7. Casey R. Ager · 1 shared paper, 2024 · strength 0.23
  8. Arthur J. Liu · 1 shared paper, 2024 · strength 0.23
  9. David S. Hong · 1 shared paper, 2024 · strength 0.23
  10. Haoqiang Ying · 2 shared papers, 2022–2023 · strength 0.23
  11. Nuh N. Rahbari · 2 shared papers, 2015–2022 · strength 0.17
  12. Christoph Reißfelder · 2 shared papers, 2015–2022 · strength 0.17
  13. Sónia A. Melo · 2 shared papers, 2015–2022 · strength 0.17
  14. Christian P. Pilarsky · 2 shared papers, 2015–2022 · strength 0.17
  15. Christoph Kahlert · 2 shared papers, 2015–2022 · strength 0.17
  16. Ya’an Kang · 2 shared papers, 2018–2019 · strength 0.14
  17. Jason B. Fleming · 2 shared papers, 2018–2019 · strength 0.14
  18. Anirban Maitra · 2 shared papers, 2018–2019 · strength 0.14
  19. Eugene Jon Koay · 2 shared papers, 2018–2019 · strength 0.14
  20. Jianjun Gao · 1 shared paper, 2023 · strength 0.12
  21. Wei Hu · 1 shared paper, 2023 · strength 0.12
  22. Youqiong Ye · 1 shared paper, 2023 · strength 0.12
  23. Cheng‐Cao Sun · 1 shared paper, 2023 · strength 0.12
  24. Liuqing Yang · 1 shared paper, 2023 · strength 0.12
  25. Jun Yao · 1 shared paper, 2023 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.